N@N

DJCI, EUFN, BIB, ALIM, GNMK, SEMG Are Seasonally Ripe To Go Down In the Next Five Weeks

May 1, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of UBS AG, Jersey Branch (NYSE:DJCI), iShares MSCI Europe Financials Sector Index Fund (NASDAQ:EUFN), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Alimera Sciences Inc. (NASDAQ:ALIM), GenMark Diagnostics Inc. (NASDAQ:GNMK), SemGroup Corporation (NYSE:SEMG) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  DJCI    UBS AG, Jersey Branch            -2.49%           85.71% (6 of 7)      Tuesday, May 9th 2017
  EUFN    iShares MSCI Europe Financials Sector Index Fund  -6.11%           100.00% (7 of 7)     Monday, June 12th 2017
  BIB     ProShares Ultra Nasdaq Biotechnology  -4.36%           85.71% (6 of 7)      Thursday, May 4th 2017
  ALIM    Alimera Sciences Inc.            -13.47%          71.43% (5 of 7)      Tuesday, May 16th 2017
  GNMK    GenMark Diagnostics Inc.         -3.55%           66.67% (4 of 6)      Wednesday, May 3rd 2017
  SEMG    SemGroup Corporation             -3.18%           85.71% (6 of 7)      Thursday, May 4th 2017

UBS AG, Jersey Branch (NYSE:DJCI) - UBS AG, a financial services firm, provides wealth management, asset management, and investment banking services to private, corporate, and institutional clients worldwide. The company also involves in retail and commercial banking in Switzerland. Its Wealth Management & Swiss Bank divisions wealth management business caters to high net worth individuals worldwide (except the Americas) whether they are investing internationally or in their home country. This division offers these clients a range of tailored advice and investment services. Its Swiss Bank business provides a set of banking services for Swiss individual and corporate clients. The companys Wealth Management Americas division offers products and services specifically designed to address the needs of high net worth and ultra high net worth individuals, and families. It includes Wealth Management U.S., domestic Canada, and the international business booked in the United States. UBS AGs Global Asset Management division provides investment solutions to financial intermediaries and institutional clients worldwide. It offers investment capabilities across various traditional and alternative asset classes, including equity, fixed income, currency, hedge fund, real estate, infrastructure, and private equity investment capabilities that could also be combined in multi-asset strategies. The companys Investment Bank division provides securities products and research in equities, fixed income, rates, foreign exchange, and metals. It also offers advisory services, as well as access to the worlds capital markets for corporate, institutional, intermediary, and alternative asset management clients. UBS AG operates in approximately 50 countries. The company was founded in 1862 and is based in Zurich, Switzerland..

iShares MSCI Europe Financials Sector Index Fund (NASDAQ:EUFN) - The investment seeks to track the investment results of the MSCI Europe Financials Index composed of developed market European equities in the financials sector. The fund generally will invest at least 90% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index designed to measure the combined equity market performance of the financials sector of developed market countries in Europe..

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) - The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index . The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified..

Alimera Sciences Inc. (NASDAQ:ALIM) - Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It focuses on diseases affecting the back of the eye or retina. The company offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness. Its ILUVIEN is inserted in the back of the patient s eye in a non-surgical procedure, which allows for a self-sealing wound by delivering a continuous microdose of the non-proprietary corticosteroid fluocinolone acetonide in the eye. The company has an agreement with pSivida US, Inc. for the development and sale of ILUVIEN, and a delivery device to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans other than uveitis or to treat DME. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia..

GenMark Diagnostics Inc. (NASDAQ:GNMK) - GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. The company provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, and thrombophilia risk test, as well as HCV genotyping test and associated custom manufactured reagents, and 2C19 genotyping test. The company also provides ePlex instrument and RP panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results without any additional steps. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California..

SemGroup Corporation (NYSE:SEMG) - SemGroup Corporation provides gathering, transportation, storage, distribution, marketing, and other midstream services for producers, refiners of petroleum products, and other market participants. Its Crude Transportation segment operates crude oil pipelines and truck transportation businesses. This segment operates a 460-mile crude oil gathering and transportation pipeline system in Kansas and northern Oklahoma; a 75-mile crude oil gathering pipeline system that transports crude oil from production facilities in the DJ Basin to the pipeline owned by White Cliffs Pipeline, L.L.C.; a 527-mile pipeline that transports crude oil from Platteville, Colorado to Cushing, Oklahoma; and a 215-mile crude oil pipeline in western and north central Oklahoma, as well as had crude oil trucking fleet of 225 transport trucks and 235 trailers. The company s Crude Facilities segment operates crude oil storage and terminal businesses. It has approximately 7.6 million barrels of crude oil storage capacity in Cushing, Oklahoma; and a 30-lane crude oil truck unloading facility with 350,000 barrels of associated storage capacity in Platteville, Colorado. Its Crude Supply & Logistics segment operates a crude oil marketing business. This segment has approximately 61,800 barrels of crude oil storage capacity in Trenton and Stanley, North Dakota. The company s SemGas segment provides natural gas gathering, processing, and marketing services. This segment owns and operates approximately 1,000 miles of gathering pipelines in Oklahoma and Texas. Its SemCAMS segment owns and operates natural gas processing and gathering facilities in Alberta, Canada. The SemLogistics segment engages in the receipt, storage, and redelivery of clean petroleum products and crude oil at the Milford Haven site, the United Kingdom. The SemMexico segment purchases, produces, stores, and distributes liquid asphalt cement products in Mexico. The company was founded in 2000 and is headquartered in Tulsa, Oklahoma..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---